Universal Fixed Meal Boluses Usage in Patients With Medtronic Minimed 780G Pumps

Launched by TARTU UNIVERSITY HOSPITAL · Apr 13, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how different meal bolus settings affect blood sugar control in children and teenagers with type 1 diabetes who use Medtronic MiniMed 780G insulin pumps. Specifically, it compares two approaches: one group will use a fixed amount of insulin for meals based on their total daily dose, while the other group will use personalized amounts tailored to their individual needs. The study will involve 20 participants aged 7 to 19 over a period of 14 days, and researchers will analyze the results to see which method works better.

To participate in this trial, candidates must be between 7 and 19 years old, have been diagnosed with type 1 diabetes for at least a year, and be using the MiniMed 780G pump for at least a month. Participants should also be taking insulin at a specific dose. Those with certain health conditions, like active coeliac disease or other chronic illnesses that could affect diabetes treatment, are not eligible. Throughout the study, participants can expect to follow their usual routines while testing these different meal bolus settings, contributing valuable information that may help improve diabetes management in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • age 7-19
• • type 1 diabetes diagnosed at least 1 year ago
• • insulin in the dose 0,5-1,0 units/day/kg
• • MiniMed 780G pump usage at least 1 month.
• Exclusion Criteria:
• • Active coeliac disease
• • Chronic disease possible to influence diabetes treatment
• • Acute disease at the moment of recruitment